Bioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient
Bioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient
复制标题
DOI：
10.1111/jocs.12604
复制
发表时间：
2015-09-01
影响因子：
1.6
通讯作者：
Barker, Colin
中科院分区：
文献类型：
--
作者：
Chaikriangkrai, Kongkiat;Goswami, Rajiv;Barker, Colin
经导管二尖瓣置入术(TMVIV)是二尖瓣置换术高危患者的一种选择。TMVIV的有效性和安全性还处于初级阶段。我们报告一位高危症状性透析依赖型终末期肾病患者，并伴有严重的生物瓣膜狭窄，他成功地进行了TMVIV。DOI：10.1111/jocs.12604(J Card Surg 2015；30：697-700)
Transcatheter mitral valve-in-valve implantation (TMVIV) is an option for patients with mitral prosthetic valve dysfunction who are at high risk for surgical valve replacement. Efficacy and safety of TMVIV is at its infancy. We report a high-risk symptomatic dialysis-dependent end-stage renal disease patient with severe bioprosthetic mitral valve stenosis who had TMVIV performed successfully. doi: 10.1111/jocs.12604 (J Card Surg 2015;30:697-700)